Hong JH, Jang S, Heo YM, Min M, Lee H, Lee YM, et al. Investigation of marine-derived fungal diversity and their exploitable biological activities. Mar Drugs. 2015;13:4137–55.
Daletos G, Ebrahim W, Ancheeva E, El-Neketi M, Song W, Lin W, et al. Natural products from deep-sea-derived fungi–a new source of novel bioactive compounds? Curr Med Chem. 2018;25:186–207.
Nagano Y, Nagahama T. Fungal diversity in deep-sea extreme environments. Fungal Ecol. 2012;5:463–71.
Matsuo H, Nonaka K, Nagano Y, Yabuki A, Fujikura K, Takahashi Y, et al. New metabolites, sarcopodinols A and B, isolated from deep-sea derived fungal strain Sarcopodium sp. FKJ-0025. Biosci Biotechnol Biochem. 2018;82:1323–6.
Matsuo H, Mokudai T, Higo M, Nonaka K, Nagano Y, Nagahama T, et al. Cipralphelin, a new anti-oxidative N-cinnamoyl tripeptide produced by the deep sea-derived fungal strain Penicillium brevicompactum FKJ-0123. J Antibiot. 2019;72:775–8.
Matsuo H, Hokari R, Ishiyama A, Iwatsuki M, Higo M, Nonaka K, et al. Hatsusamides A and B: two new metabolites produced by the deep-sea-derived fungal strain Penicillium steckii FKJ-0213. Mar Drugs. 2020;18:513.
Azami H, Watanabe Y, Sakai K, Nakahara H, Kojima H, Tokiwa T, et al. Antifungal profile against Candida auris clinical isolates of tyroscherin and its new analog produced by the deep-sea-derived fungal strain Scedosporium apiospermum FKJ-0499. J Antibiot. 2024;77:156–62.
Takahashi K, Sakai K, Nagano Y, Orui-Sakaguchi S, Lima AO, Pellizari VH, et al. Cladomarine, a new anti-saprolegniasis isolated from the deep-sea fungus, Penicillium coralligerum YK-247. J Antibiot. 2017;70:911–4.
Nonaka K, Ōmura S, Masuma R, Kaifuchi S, Masuma R. Three new Pochonia taxa (Clavicipitaceae) from soils in Japan. Mycologia. 2013;105:1202–18.
Ouchi T, Watanabe Y, Nonaka K, Muramatsu R, Noguchi C, Tozawa M, et al. Clonocoprogens A, B and C, new antimalarial coprogens from the Okinawan fungus Clonostachys compactiuscula FKR-0021. J. Antibiot. 2020;73:365–71.
Harada K, Fujii K, Hayashi K, Suzuki M, Ikai Y, Oka H. Application of d,l-FDLA derivatization to determination of absolute configuration of constituent amino acids in peptide by advanced Marfey’s method. Tetrahedron Lett. 1996;37:3001–4.
Otoguro K, Ui H, Ishiyama A, Arai N, Kobayashi M, Takahashi Y, et al. In vitro antimalarial activities of the microbial metabolites. J Antibiot. 2003;56:322–4.
Iwatsuki M, Uchida R, Takakusagi Y, Matsumoto A, Jiang CL, Takahashi Y, et al. Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171. J Antibiot. 2007;60:357–3.
Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389–402.
Samson RA, Gams W. Typification of the species of Aspergillus and associated teleomorphs. In: Samson RA, Pitt JI (editors). Advances in Penicillium and Aspergillus systematics. New York, NY: Springer; 1985, Vol. 31 pp. 31–54.
Song Z, Hou Y, Yang Q, Li X, Wu S. Structures and biological activities of diketopiperazines from marine organisms: a review. Mar Drugs. 2021;19:403.
Kozlovskiĭ AG, Vinokurova NG, Adanin VM. Diketopiperazine alkaloids from the fungus Penicillium piscarium Westling. Prikl Biokhim Mikrobiol. 2000;36:317–21.
Steyn PS. The structures of five diketopiperazines from Aspergillus ustus. Tetrahedron. 1973;29:107–20.
Kozlovsky A, Vinokurova NG, Adanin VM, Gräfe U. Piscarinines, new polycyclic diketopiperazine alkaloids from Penicillium piscarium NKM F-691. Nat Prod Lett. 2000;14:333–40.
Zhuravleva OI, Afiyatullov SSH, Denisenko VA, Ermakova SP, Slinkina NN, Dmitrenok PS, et al. Secondary metabolites from a marine-derived fungus Aspergillus carneus Blochwitz. Phytochemistry. 2012;80:123–31.
Peng J, Gao H, Li J, Ai J, Geng M, Zhang G, et al. Prenylated indole diketopiperazines from the marine-derived fungus Aspergillus versicolor. J Org Chem. 2014;79:7895–904.
Ishiyama A, Hokari R, Nonaka K, Chiba T, Miura H, Otoguro K, et al. Diatretol, an α, α‘-dioxo-diketopiperazine, is a potent in vitro and in vivo antimalarial. J Antibiot. 2021;74:266–8.
Ceravolo IP, Leoni LF, Krettli AU, Murta SMF, de M Resende D, de ML Cruz MGF, et al. Novel 2,5-diketopiperazines with in vitro activities against protozoan parasites of tropical diseases. Pharmaceuticals. 2024;17:223.
Raju R, Piggott AM, Conte M, Aalbersberg WGL, Feussner K, Capon RJ. Naseseazines A and B: a new dimeric diketopiperazine framework from a marine-derived actinomycete, Streptomyces sp. Org Lett. 2015;11:3862–5.
Buedenbender L, Grkovic T, Duffy S, Kurtböke DI, Avery VM, Carroll AR. Naseseazine C, a new anti-plasmodial dimeric diketopiperazine from a marine sediment derived Streptomyces sp. Tetrahedron Lett. 2016;57:5893–5.
